Nonsense-mediated mRNA decay is a eukaryotic pathway that degrades transcripts with premature termination codons (PTCs). In most eukaryotes, thousands of transcripts are degraded by NMD, including many important regulators of development and stress response pathways. Transcripts can be targeted to NMD by the presence of an upstream ORF or by introduction of a PTC through alternative splicing. Many factors involved in the recognition of PTCs and the destruction of NMD targets have been characterized. While some are highly conserved, others have been repeatedly lost in eukaryotic lineages. Here, I outline the factors involved in NMD, our current understanding of their interactions and how they have evolved. I outline a classification system to describe NMD pathways based on the presence/absence of key NMD factors. These types of NMD pathways exist in multiple different lineages, indicating the plasticity of the NMD pathway through recurrent losses of NMD factors during eukaryotic evolution. By classifying the NMD pathways in this way, gaps in our understanding are revealed, even within well studied organisms. Finally, I discuss the likely driving force behind the origins of the NMD pathway before the appearance of the last eukaryotic common ancestor: transposable element expansion and the consequential origin of introns. Keywords RNA, NMD, evolution, UPF1, SMG1, transposable element, RNA decay Creative Commons Attribution Licence permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
What is nonsense-mediated mRNA decay?
Gene expression is controlled by a variety of mechanisms, sometimes in unexpected ways. Early mutant screens identified mutations that introduced nonsense mutations, but surprisingly, these premature termination codons (PTCs) lead to a reduction in mRNA stability 1, 2 . This increase in RNA decay is the result of an active translation-dependent process 1, 3 . This pathway was termed nonsense-mediated mRNA decay (NMD) and is now known to regulate hundreds to thousands of transcripts in plants, animals and fungi [4] [5] [6] [7] [8] . Many of the NMD targeted transcripts are not the result of nonsense mutations, but are instead the result of alternative splicing events that introduce PTCs or the presence of an upstream open reading frame (uORF). Many such splicing events are not the result of splicing errors, but are in fact highly conserved events 9, 10 . Therefore, NMD has a major role in shaping the transcriptome of diverse eukaryotes. However, the exact molecular nature of the NMD pathway varies between organisms. Most eukaryotes share the core NMD factors (see below), but an impressive number of modifications to the NMD pathway exist. In this review, I will examine the factors known to act in NMD, discuss the diversity of these factors in eukaryotes, and explore the different mechanisms that explain how a PTC is differentiated from an authentic stop codon. Finally, I will discuss how the NMD pathway may have evolved and some remaining key questions in our understanding of the NMD pathway.
The factors that read nonsense
Early mutant screens in baker's yeast and Caenorhabditis elegans identified three conserved factors that could suppress a nonsense mutation 11, 12 . These factors were named UPframeshift (UPF) 1, 2 and 3 in baker's yeast and suppressors with morphological defects on genitalia (SMG) 2, 3 and 4 in C. elegans. The baker's yeast names of these factors are used throughout this review. UPF1 is a highly conserved RNA helicase 13 that interacts with UPF2, which is an MIF4G domaincontaining protein 14 , that in turn binds to UPF3 (Figure 1 ) 15, 16 . The initial mutant screens in C. elegans also revealed four additional factors: the kinase SMG1 and the 14-3-3-like domain proteins SMG5, SMG6 and SMG7 11, 17 . In animals, SMG1 is known to phosphorylate UPF1 after a PTC is been recognised (Figure 1 ) [18] [19] [20] . Initially, NMD factors were defined by their role in the phosphorylation of UPF1. UPF2 and UPF3 support the phosphorylation of UPF1 by creating a complex compatible for Figure 1 . The model of NMD activation in animals. At termination events, UPF1 and SMG1 are recruited to termination events by eRF1 and eRF3, leading to the formation of the SMG1-Upf1-eRF1-eRF3 (SURF) complex 20 . If an EJC, bound by UPF3 and UPF2, is present downstream of the terminating ribosome, then the decay-inducing (DECID) complex will form 20, 21 . This will lead to the phosphorylation of UPF1 by SMG1. Then the ribosome will disassociate and SMG5-7 will be recruited to transcript through phoso-UPF1 binding. The transcript is degraded by nucleases.
phosphorylation by SMG1 20 , while also acting to activate the RNA helicase activity of UPF1
22
. SMG5-7 bind to phosphorylated UPF1 23 and are active in the dephosphorylation of UPF1 by recruiting the PP2A phosphatase [24] [25] [26] . However, it is now clear that their primary role is in acting at various stages of RNA decay. SMG5-7 have a central role in recruiting the degradation machinery to degrade the NMD target (Figure 1 ). SMG5 and SMG7 act to recruit exonucleases 27 , while SMG6 is an endonuclease, cutting the transcript near the PTC 28, 29 . Over time, many more NMD factors have been identified through further genetic and biochemical screens [30] [31] [32] [33] . Of these, SMG8 and SMG9 are of particular interest. First identified in human cells as SMG1-interacting proteins, they act in the NMD pathway of humans and possibly C. elegans 32, 34 through the inhibition of the kinase SMG1. Curiously, studies in mammals have revealed that many NMD targets do not require the involvement of all NMD factors. Many NMD targets use "branches" of the NMD pathway that do not require UPF2 35 or UPF3b 36 . However, all branches do involve UPF1, highlightings its central importance to the NMD pathway.
Together these studies, mostly using animal systems, paint a picture where multiple factors (UPF2, UPF3, SMG1, SMG8, and SMG9) assist in the activation of UPF1, while other factors (SMG5-7) act to degrade an NMD target and dephosphorylate UPF1.
Variations on a common pathway
Despite the deduction of a basic schematic of the NMD pathway in animals ( Figure 1 ), many of the factors involved in this classical model of NMD vary between different organisms (Figure 2 and Figure 3 ). The most highly divergent NMD pathways are those found in the excavata (Figure 2 and Figure 3 ). The excavata have been suggested to be the most basal group of eukaryotes 37 , although other work places them within the same supergroup as plants 38, 39 . Although the NMD pathways of the parasites Giardia lamblia and Trypanosoma brucei have been studied, it is unclear if a functional NMD pathway exists in these organisms 40, 41 . They contain heavily reduced compliments of NMD factors: the genome of G. lamblia only harbors UPF1, and the genome of T. brucei only harbors UPF1 and UPF2 40, 41 . Over-expression of UPF1 in G. lamblia caused an NMD reporter to further decrease, suggesting that G. lamblia might have an active NMD pathway 40 . In contrast, the knockdown of UPF1 in T. brucei did not increase NMD reporter construct expression, or endogenous genes 41 . However, tethering of UPF1 in T. brucei did decrease reporter expression 41 . Therefore, it is difficult to definitively conclude the status of the NMD pathway in excavata. However, it is worth noting that parasites are known to have reduced genomes relative to free-living relatives 42 , and that the excavata Naegleria gruberi does harbor the additional NMD factors of SMG1 and SMG9 43 . This indicates that a complex NMD pathway involving the kinase SMG1 likely existed in the last eukaryotic common ancestor.
Further support for this comes from the examination of plant NMD pathways. Plants, which diverged from animals and fungi early in eukaryotic evolution (Figure 2 ), do have functional The distribution of the key NMD factors, UPF1, SMG1 and a member of the SMG5-7 family define the NMD pathway type. All NMD types have arisen multiple times within eukaryotic evolution. To date, no SMG5-7 family member has yet been identified in Naegleria gruberi but given the presence of SMG1 43 , I am currently classifying it as a type 1 NMD pathway. The branch lengths do not reflect the relatedness of any species, but represent the order of separation between the lineages. The root of eukaryotes is unclear, so branches representing a Excavata early and late divergence are represent in grey, dashed-lines. *SMG1 appears to have been lost in other fungal lineages as well, representing repeated losses in multiple fungal lineages 43 . NMD pathways can be classified into four types (Figure 3) . homologues of the NMD holy trinity: UPF1-3 49, 50 . Plants also have homologues of SMG5-7, known as SMG7 and SMG7-like 45 , and SMG1 homologues 43, 44 . SMG1 has been repeatedly lost throughout eukaryotic evolution, including two losses in land plants (Arabidopsis thaliana and Capsella rubella) and multiple losses in fungi (Figure 2 ) 43, 44 . The repeated loss of SMG1 raises some interesting questions about the mechanism of NMD activation. In animals, and presumably in most plants, SMG1 phosphorylates SQ and TQ dipeptides at the N-and C-termini of UPF1 18, 46, 51 . Species, such as baker's yeast, with an ancient loss of SMG1 (Figure 2 ), have UPF1 sequences depleted of S/TQ dipeptides relative to species with SMG1 43 . Species that lost SMG1 more recently, such as A. thaliana, have UPF1 proteins that are rich in S/TQ dipeptides 43 . The repeated losses of SMG1 in eukaryotes suggests that there is a genetic buffer, another factor/mechanisms that allows SMG1 to be lost but the NMD pathway to be activated 43, 44 . In support of this notion, the experimental perturbation of SMG1 in fruit flies and zebrafish has little or no effect on the NMD pathway of these organisms 52-54 , suggesting that a backup UPF1-activation mechanism is already present in these species. Alternatively, different mechanisms have replaced SMG1 in each independent loss of SMG1, which might explain why some organisms have retained S/TQ richness within their UPF1 protein sequences while others have not 43, 44 .
The SMG5-7 family split and diversified in the animal lineage, with the acquisition of the PIN domain in SMG5 and SMG6 26, 55, 56 . The PIN domain of SMG6 gives it the ability to act as an endonuclease, cutting the NMD targeted transcript near the PTC 28, 29 . The SMG5-7 family also have a role in regulating telomere length 57 . SMG5-7 homologues in plants are known as SMG7, given they lack the PIN domain of SMG5 and SMG6
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. SMG5-7 family members of baker's yeast, EBS1 and ETS1, also lack the PIN domain 48 . In baker's yeast, ETS1 is implicated in telomere regulation but not NMD, while a knockout of EBS1 reveals a mild NMD phenotype 48 . Given that baker's yeast lacks SMG1 19, 43, 44 , it is not clear why EBS1/SMG7 would be required for NMD. The UPF1 of baker's yeast is depleted of S/TQ dipeptides 43 , which once phosphorylated by SMG1, normally act as binding site for . The lack of S/TQ dipeptides suggest that classical phosphorylation of UPF1 is not required for the activation of NMD in baker's yeast. Tyrosine phosphorylation of UPF1 in baker's yeast has been observed and appears to regulate the RNA helicase activity of UPF1
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. It is possible that these or other phosphorylated sites could act to recruit decay factors like S/TQ dipeptides do. However, given the differences between S and T residues from Y, it seems unlikely that EBS1/SMG7 would be involved. Recently, another member of the SMG5-7 family was characterized in the ciliate Tetrahymena thermophila 59 , despite the loss of the SMG1 kinase from T. thermophila 43, 59 . The SMG5-7 family member of T. thermophila was named SMG6-like (SMG6L) due to the presence of the C-terminal NYN nuclease domain, potentially taking on the same role as the PIN domain of animal SMG6 proteins 59 . SMG6L appears to work with UPF1 in the NMD pathway of T. thermophila and is conserved in many other protozoa 59 . However, it is unclear how it is recruited to UPF1 given the lack of SMG1 and classical phosphorylation sites on UPF1.
The kinase activity of SMG1 is regulated in part by SMG8 and SMG9 32 . These factors have been identified but not characterized outside of the animal kingdom 43 ; a curious finding which indicates they may have a role in NMD in diverse eukaryotes. When SMG1 is lost from a genome, SMG8 and SMG9 are generally also lost 43 . Further work will be needed to reveal the extent of any conserved role in NMD for these factors.
Taken together, a diverse set of NMD pathways with varying levels of classically defined NMD factors been identified. Generally speaking, these can be split into four major types ( 2) Recent SMG1-independent NMD (As exemplified by A. thaliana)
3) Ancient SMG1-independent NMD (As exemplified by baker's yeast and T. thermophila)
4) Heavily derived NMD (As exemplified by G. lamblia, T. brucei and Cyanidioschyzon merolae)
Type 1 NMD pathways (classical SMG1-dependent NMD; Figure 3A ) are known to exist in both animals and plants 18, 19, 44 and is likely to be the ancestral state of NMD 43, 44 . However, even here, the dependence on SMG1 is not always clear: SMG1 mutants in fruit flies have much milder phenotypes than mutations in other NMD factors 53, 60 and knockdown of SMG1 in zebrafish revealed no phenotype 54 . It is possible that the NMD pathways of some species with a type 1 NMD pathway in appearance might better resemble type 2 NMD (Recent SMG1-independent NMD).
Type 2 NMD pathways (recent SMG1-independent NMD; Figure 3B ), such as those of the land plants A. thaliana and C. rubella, appear very much like those of type 1, with the exception of SMG1 being absent from the genome, likely with the accompanying loss of SMG8 and SMG9 43, 44 . However, UPF1 still maintains the relatively high level of S/TQ dipeptide phosphorylation sites 43 , and phospho-UPF1 binding protein SMG7 8, 45 . It would be tempting to speculate that a kinase related to SMG1 replaced it in the NMD pathway 44 . ATM and ATR are two kinases from the same family as SMG1 that are conserved in plants and are involved in DNA repair. However, in A. thaliana, the reported mutant phenotypes of ATM and ATR 61 do not overlap with the classical NMD phenotypes 49 , so this seems unlikely to be the case.
A type 3 NMD pathway (ancient SMG1-independent NMD; Figure 3C ), was the first to be characterized by a mutant screen in baker's yeast 12, 62 . These ancient losses of SMG1 lead to an NMD pathway without SMG1, without SMG8 and SMG9 43 , with UPF1 depleted in S/TQ dipeptides 43 , and an unclear role for SMG5-7 proteins 48, 59 . Future work (see below) will be needed to better understand the exact molecular role of SMG5-7 proteins in type 3 NMD pathways, and to understand how the NMD pathway functions without the SMG1 activating UPF1.
Type 4 NMD pathways (heavily derived NMD; Figure 3D ) are the most variable group and are found throughout the eukaryotic tree of life. These pathways often lack SMG1, but also core NMD factors (UPF2 and UPF3). Although UPF3 is hard to identify with homology searches 63 , it does appear to be missing from the genomes of a number of species 43 . These include the excavata parasites G. lamblia and T. brucei 40, 41 but also the red algae C. merolae 44 . C. merolae has a very reduced genome, with only 27 introns in total 64 . C. merolae and G. lamblia also lack homologues of UPF2. It is certainly possible that the presence of these factors do not represent a fully functional form of an NMD pathway and instead reflect the molecular reminance of a former NMD pathway whose factors have not been co-opted for other functions.
In any of these species, additional NMD factors are likely to have arisen. PNRC2 is a vertebrate-specific NMD factor 33 . The only non-type 1 species to have had a forward genetics screen performed for is the baker's yeast, so we have limited unbiased studies to draw from. More forward screens and biochemical studies are likely to yield more species-specific factors. This will be especially exciting in type 4 species, with the most heavily reduced NMD pathways. This framework of NMD types based on presence/absence of conserved NMD factor is aimed at aiding the comparison and discussion of NMD pathways from diverse organisms. Thinking of all NMD pathways as being fundamentally the same at the molecular level is wrong. There is certainly an overlap, but more focused studies are needed to understand when homologous NMD factors do have the same molecular role in NMD and do not.
Defining NMD targets
So far I have discussed the molecular processes that link the recognition of a PTC to transcript destruction. However, a lot of work has also been focused on understanding the mechanism of how a PTC is differentiated from an authentic stop codon. Multiple models for how this is achieved have been proposed. One of the most well characterized models centres around the exon junction complex (EJC), a protein complex deposited on an mRNA after two exons are ligated together during splicing 65, 66 . While most EJCs are removed from the transcript by the translating ribosome 67 , EJCs associated with exon-exon junctions ≥50 nt downstream of a stop codon are not removed and can elicit NMD 68, 69 . Early work showed that the EJC was not involved in the NMD pathways of fruit flies 56 , but more recent work proved the contrary, revealing a role for the EJC in fruit fly NMD
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. The EJC has been lost from baker's yeast and so cannot have a role in its NMD pathway, but the EJC is involved in the fungi Neurospora crassa's NMD pathway 71 . The EJC mode has even found support in plants, with reporter genes and transcriptome-wide studies supporting a role for exon-exon junctions in 3' UTRs eliciting NMD 50, [72] [73] [74] . These findings would suggest that the EJC mode is an ancient mechanism for targeting transcripts to NMD. A surprising version of the EJC mode is the finding that NMD in T. thermophila is dependent on splice junctions downstream of the stop codon, but not on the EJC itself 59 . Knockout of the core EJC component Mago nashi did not alter the expression levels of NMD targets identified by knockout of UPF1 and SMG6L 59 . This indicates that an alternative mechanism might maintain an EJC-like mode of NMD in T. thermophila.
Another well-explored system used in defining PTCs is the long 3' UTR mode. Transcripts with abnormally long 3' UTRs have been found in reporter genes 50, 72, 75 and transcriptome-wide studies 5, 73, 76 to target transcripts to NMD, although some recent transcriptome-wide studies found little to no trend across the transcriptome, when the presence of 3' UTR introns were taken into account 59, 74, 77, 78 . One proposed mechanism is the increased distance between the stop codon (PTC) and the polyAbinding protein, bound to the polyA tail 79, 80 . This physical separation between the polyA tail and the terminating ribosome might lead to aberrant termination and the recruitment of NMD factors 79, 80 . An alternative model posits that longer 3' UTRs are able to recruit more UPF1 directly bound to the 3' UTR 81 . It has been found that UPF1 coats transcripts, but translation displaces UPF1 from all regions, except the 3' UTRs 82 . This model suggests that a higher level of UPF1 binding increases the chances of NMD being triggered during the termination of translation; Naturally long 3' UTRs that are resistant to NMD have been observed to bind less UPF1 than susceptible long 3' UTR transcripts 81 . In fact, some naturally long 3' UTR transcripts appear to be protected from NMD by various features such as a recently identified cis-sequence element in the TRAM1 gene 83 or the many genes found to bind PTBP1 near the stop codon to prevent NMD
84
. Such features protecting long 3' UTR transcripts from NMD might explain why transcriptome-wide studies find so few long 3' UTR transcripts that are targeted to NMD.
In baker's yeast, a downstream sequence element (DSE) was identified 85, 86 . When this sequence is downstream of a stop codon, NMD is elicited, likely through the recruitment of an RNA binding protein 85, 86 . This mechanism is very similar to the way in which the EJC mode works in animals and plants. The existence of DSEs in other species are possible, but to date, none have been identified. Fission yeast also display an unusual PTC recognition mechanism, not yet observed in other species: splicing near a stop codon, either upstream or downstream of the stop codon, can induce NMD and is independent of the EJC 87 . Whether such a mechanism exists in other eukaryotes and what factors determine this remain to be seen.
The mechanisms used to define PTCs in the last eukaryotic common ancestor are unclear. While the EJC mode has been identified in both plants and animals, suggesting an ancient origin, there are many eukaryotic lineages where it has not been characterized, or does not function 59, 87 . The long 3' UTR mode of NMD has also been characterized in many diverse eukaryotes (plants, animals and fungi), but the mechanism underlying this mode, and failure to observe a strong signal for this feature in transcriptome-wide studies, does raise questions.
The origins of NMD
Today, eukaryotes appear to utilize NMD in a variety of ways to achieve the same aim, degrading PTC-containing transcripts from a variety of sources. It is clear that a rather complex NMD pathway, belonging to the type 1 group, existed in the last eukaryotic common ancestor (see above). In extant diploid eukaryotes, NMD can prevent some mutations from being dominant, protecting heterozygous individuals by turning these alleles recessive 11, 88, 89 . However, NMD also increases the severity of some genetic disorders 90 , creating a double-edged sword: protecting some mutation-carrying individuals while exacerbating the conditions of others. Therefore, it is unlikely that protecting the genome from nonsense mutations was the driving force behind the origin of the NMD pathway. Early eukaryotes did face a particular selective pressure not present in prokaryotes: rapidly multiplying transposable elements (TEs). The origin of sex in eukaryotes allowed for TEs to expand in copy number, which is not possible in prokaryotes with their primarily asexual reproductive system 91, 92 . With the advent of sex, eukaryotes faced the expansion of many TE classes, including the self-splicing (group II) introns. Expansion of group II introns has been proposed to have driven the evolution of the spliceosome to enhance the splicing of these selfish elements 93 , the nucleus evolved to physically separate the processes of transcription and translation and allow for intron removal before translation 94 , and NMD evolved to degrade intron-retaining transcripts that escaped the nucleus 94 . These adaptations ensure that retention of these efficiently-spliced introns would not be repeatedly translation. More recent expansions of introns in some eukaryotic lineages are due to the expansion of DNA transposons 95 , indicating the importance of these mechanisms to protect the genome from TE expansions in extant eukaryotes, and suggests multiple origins for introns from TEs throughout eukaryotic evolution. Once functional as a TE-intron protection pathway, NMD appears to have been co-opted to control gene expression. Today, in addition to repressing the expression of uORF-containing genes, pseudogenes and the products of alternative splicing, NMD may allow for the evolution of new introns. The presence of NMD may act as a buffer for novel introns with weak splice sites 96 . In fact, the red algae C. merolae only has 27 introns 64 and is missing all of the classical NMD factors with the exception of a UPF1 homologue 44 . It is possible that C. merolae lacks a functional NMD pathway and this limits the acquisition of new introns, at least partly explaining its intron depleted genome.
Unanswered questions
Many years of study have revealed diverse NMD pathways, centering on UPF1. However, there are a number of fundamental questions remaining in the field regarding the mechanisms and evolution of NMD. 6) To understand the discrepancies between transcriptomewide and reporter construct approaches to the long 3' UTR mode of NMD and to uncover the molecular mechanism(s) behind the long 3' UTR mode.
Hopefully future research efforts can resolve these and other unknowns surrounding NMD.
Conclusion
Here I have discussed the NMD pathway in the context of evolution and the many shapes the NMD pathways takes. I have proposed a classification system with four types of NMD pathway, based on the presence/absence of conserved NMD factors. I propose that the classical (type 1) NMD involves UPF1-3, the UPF1-kinase SMG1 and the SMG5-7 family. The recent (type 2) and ancient (type 3) loss of SMG1 define the next two types of NMD, while loss of all but UPF1 and perhaps UPF2 define the final type (type 4), where NMD might not actually function at all. It is highly likely that species specific NMD factors have been co-opted in many, if not all, of these types of NMD pathway and are waiting to be discovered. Discussing the evolution and mechanism of NMD within this framework will hopefully aid in the communication of ideas between different model systems used to study NMD and therefore help in knowledge acquisition. Finally, I outline key outstanding questions regarding the mechanism and evolution of the NMD pathway. Focused research efforts to address these issues will certainly help in our overall understanding of the NMD pathway and for us to at last appreciate the true fundamental nature of NMD.
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3. The nonsense-mediated mRNA decay pathway is found throughout eukaryotes, where it performs important quality control and regulatory functions. How the pathway originally emerged and has subsequently adapted to diverse eukaryotic transcriptomes is an important but poorly understood question. This manuscript represents a helpful summary of the evidence for compositionally-and mechanistically-distinct NMD pathways in diverse eukaryotes and raises interesting questions that deserve future study.
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Major points:
The review raises the question of how RNA decay machinery is recruited to NMD substrate mRNAs in organisms that have lost SMG1. Work from yeast and human cells give two possible answers to this question. First, the Jacobson and Parker labs have presented evidence that budding yeast UPF1 directly interacts with components of the decapping complex, enabling SMG1-and SMG6-independent decay . Second, the Conti and Muhlemann groups have shown that SMG6 can interact with UPF1 in a phosphorylation-independent manner. Their data suggest that UPF1 phosphorylation may be dispensable for SMG6 recruitment but may contribute to activation of its endonucleolytic activity, raising the possibility that a SMG-1 independent pathway could rely on phosphorylation-independent SMG6-UPF1 interactions coupled with a distinct mechanism for activation of SMG6.
Figure 3: The schematics in the figure suggest that there is a universal step of mRNP remodeling that involves ribosome displacement from target mRNAs prior to initiation of decay, but it is not clear that this is the case. Previous work from the Baker lab has indicated that budding yeast NMD can initiate on polysome-bound mRNAs, rather than those stripped of ribosomes . In addition, this figure and Figure 1 should acknowledge that there is evidence that "classical" NMD can also proceed through deadenylation, decapping, and exonucleolytic decay, not just SMG6-mediated cleavage. For other organisms, "cleavage" implies an endonucleolytic step, which in organisms lacking SMG6 is not known to occur. As referenced above, yeast NMD proceeds through decapping, and this should be made clear in the figure.
It would be helpful to note that in Drosophila, a much more significant role for SMG1 is uncovered in SMG5 mutants . This is consistent with the idea that organisms such as Drosophila have developed redundant pathways for NMD. However, this also means that the extent to which "the dependence on SMG1 is not always clear" may be overstated. The fact that SMG1 has been 1,2 3,4 5 6 3.
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dependence on SMG1 is not always clear" may be overstated. The fact that SMG1 has been maintained in this organism and can function in at least some contexts should carry greater weight than the failure to observe a strong phenotype in the limited experimental contexts in which it has been examined.
Page 6, second paragraph: It is somewhat misleading to state that "transcriptome-wide studies find so few long 3'UTR transcripts that are targeted to NMD." It is true that there have been differing reports of the extent to which 3'UTR length correlates with decay susceptibility transcriptome-wide, but this is not the same as saying that these studies did not find evidence that substantial numbers of long 3'UTR-containing transcripts are subject to NMD. In addition, it is important to recognize that the Lindeboom study cited here examined apparent NMD susceptibility of mRNAs et al. with nonsense mutations, not the scope of long 3'UTR-mediated decay among normal transcripts .
Page 6, second paragraph, continued: The poly-A binding protein-centric model and the UPF1 length-sensing model are not necessarily exclusive. It has been reported that Pab1 and poly-A tails are dispensable for accurate NMD target discrimination in yeast , but it is possible that UPF1 binding contributes to competition between poly-A binding protein and NMD factors for binding to release factors at the terminating ribosome. Another emerging possibility is that PABP antagonizes UPF1 binding to 3'UTRs, as proposed by Lee . et al.
Minor points:
It would be helpful to the reader to reference recent evidence that PNRC2 may function in general decapping but contribute minimally to NMD in vertebrates .
Page 2, second paragraph: Since UPF2 and UPF3 were identified and initially characterized in yeast, in which UPF1 phosphorylation is not known to play a key role in decay, the basis for the statement that "initially, NMD factors were defined by their role in the phosphorylation of UPF1" is unclear.
Page 2, first paragraph: The Maquat 1981 paper was not based on a "mutant screen" but et al., instead observations in human genetic disease . Figure 1 implies that the roles of UPF2 and UPF3 are dependent on the EJC, but this is not the case -these proteins have been found to be required for decay of NMD substrates lacking 3'UTR introns .
At several points, it is not clear whether the authors use the nomenclature 'SMG5-7' to refer to SMG5, 6, and 7, or just SMG5 and 7, as is the more standard usage. For example, on Page 3, first paragraph, it should be made clear that SMG6 does not function in "recruiting the degradation machinery" but is itself an endonuclease.
Page 5, fifth paragraph. It is possible that other PIKK-type kinases other than ATM and ATR are re-purposed to phosphorylate UPF1.
Discussion of the Tetrahymena data should acknowledge that at this point the evidence for a role 8.
Discussion of the Tetrahymena data should acknowledge that at this point the evidence for a role for exon junctions is correlative and remains to be mechanistically investigated. This is an important caveat to the classification system offered by the author .
translational fidelity as a basis for substrate selection. In this review, the author suggests a novel NMD classification system based on the evolutionary conservation of known NMD factors among different species. The author also discusses a possible driving force for the apparition of NMD. This is a well-written and structured manuscript considering NMD under an interesting evolutionary point of view. It is of broad interest for the NMD community, and it mentions several fundamental questions currently unanswered in the NMD field. Nevertheless, a few modifications of the figures and the addition of some very important references and concepts could make it easier to read and broaden the general interest of the review, as detailed in the following paragraphs.
Major comments:
In Figure 1 , the model of mammalian NMD indicates cleavage of the NMD target downstream of the PTC. It doesn't indicate the distinct roles of SMG6 and SMG5/7; it would be important here to indicate the distinct involvement of SMG6 in the cleavage activity and the role of SMG5/7 in decay factors recruitment. These two routes for decay should clearly appear in Figure 1 .
In Figure 2 , the definition of Type 1/2/3/4 NMD should already be mentioned in the figure legends (e.g. Type 1: classical SMG1 dependent NMD, Type 2: recent loss of SMG1 with conserved phosphorylation, Type 3: ancient loss of SMG1 with loss of UPF1 S/Q phosphorylation, Type 4: Heavily derived NMD).
In the paragraph 'Defining NMD targets' the author cites the 2016 paper on the NMD protection , effect of PTB1; an earlier study describing similar protection effect of Pub1 in yeast should also be cited (Ruiz-Echevarria and Peltz, 2000 ) .
In the same paragraph, the author focuses on Baker's yeast DSE, stimulating NMD. The author should also mention a recent paper in yeast describing that poor translation efficiency is a major criteria for NMD targeting (Celik et al., 2017 ) . This major result could potentially explain not yet understood deregulations observed in several other species upon NMD knockdown.
It was proposed that invading RNAs of external origin, including TEs and viruses, could be a 
2.
4.
It was proposed that invading RNAs of external origin, including TEs and viruses, could be a driving force for NMD apparition and evolution -this should be mentioned in the paragraph on the possible origin of NMD (Hamid and Makeyev, 2016 ) .
Minor comments:
UPF1 might have other essential functions beyond NMD, as observed for UPF3b in mammals, involved in translation termination (Neu-Yilik et al., 2017 ) , which could explain its presence in some species without any other known NMD factors. This could be mentioned in the corresponding section.
As branches of NMD exist without the need of UFP2/UPF3, it suggests that NMD could be active with only UPF1. This possibility should be discussed/mentioned when describing Type 4 species depleted of UPF2 and UPF3.
In addition to ATR/ATM, the author could mention TOR or TRRAP kinases as described in (Lloyd and Davies, 2013 ) , as possible kinase replacements for SMG1.
In Figure 3 , the author should add precisions on endonucleolytic cleavage and decay factor recruitment for , and decay factor recruitment only for the others. The different types of NMD (A) defined in Figure 2 should be mentioned again here in Figure 3, In this manuscript, the author discussed the diversity of the NMD pathway according to the variation of NMD factors in different eukaryotes, and briefly summarized some popular NMD models. Furthermore, the author also discussed the relationship between intron gain/loss and NMD. Several interesting and unsolved questions in this field were also mentioned by the end of the manuscript. Interestingly, the author came up with a novel classification system (although it needs to be further modified, see below) to classify NMD mechanisms into different types based on the new criterion. Namely, it classifies NMD mechanisms according to the presence or absence of key factors that related to the well-characterized Upf1 C-terminus phosphorylation events. The manuscript is clearly written, and this work is likely to be of general interest to the NMD field. My main criticism is about the novel classification system.
Major
As it is still unclear whether excavates have functional NMD, the type 4 NMD may not need to be taken into account. Or question marks should be included in the figure 2 and figure 3D , and in the main text.
Type 1 NMD seems to be SMG1-dependent and EJC-dependent (see figure 3A) . Hence it cannot be exemplified by C. elegans (EJC-independent NMD). The author could modify the figure a little. For example, one could draw EJC with a dashed line to indicate it is dispensable for NMD in some organisms, like C. elegans. Besides, the presence of Smg1 and Upf1 orthologs in N. gruberi does not necessarily mean it possesses a functional NMD pathway, thus I suggest not consider it has type 1 NMD. Or, as I mentioned above, excavates need not be discussed too much.
As mentioned by the author, some organisms (e.g., D. melanogaster and D. rerio) are considered to have SMG1-dependent type 1 NMD, yet their SMG1 proteins are dispensable for NMD activation and therefore similar to the type 2 NMD. I am wondering whether this issue can be solved by defining another type of NMD, namely in between type 1 and type 2. Besides, an additional figure (e.g., figure 3 in (Lareau and Brenner, 2015 ) could be provided to show the evolutionary relationship between different types of NMD.
Figure 2 needs to be modified. Clearly, solely based on the pattern of these icons (NMD proteins), readers may get confused why organisms with the same pattern are not classified into the same group. For example, like C. rubella, Tetrahymena also has a red square and a blue triangle. However, they are classified into different types. Although, in this case, it can be easily solved by adding another icon to indicate Upf1 with phosphorylatable S/TQ motifs. Additional modifications are required to let readers understand, for example, why Dikarya and Mirosporia are considered as 1 The peer review process is transparent and collaborative Your article is indexed in PubMed after passing peer review Dedicated customer support at every stage For pre-submission enquiries, contact research@f1000.com
